Long Term Immunity and Safety Following Vaccination With the JEV IC51 (IXIARO®, JESPECT®) in Pediatric Population In Non Endemic Countries. Uncontrolled, Ph3 FU-Study

NCT01246479 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

23

Enrollment

INDUSTRY

Sponsor class

Conditions

Japanese Encephalitis

Interventions

PROCEDURE: Blood draw
BIOLOGICAL: IC51 has given in the parent study IC51-322

Sponsor

Valneva Austria GmbH